SCHEMBL6479814

SCHEMBL6479814

[CH2]c1c2c(nc3ccccc13)COC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 7/20 0.42
BCHE P06276 5/20 0.42
ALDH1A1 P00352 5/20 0.40
HSD17B10 Q99714 4/20 0.40
CYP1A2 P05177 4/20 0.40
CYP2D6 P10635 4/20 0.40
KDM4E B2RXH2 4/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2C19 P33261 3/20 0.40
TSHR P16473 3/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 2/20 0.40
CASP1 P29466 1/20 0.40
CACNB4 O00305 1/20 0.39
CACNA1A O00555 1/20 0.39
SLC22A2 O15244 1/20 0.39
SLC22A1 O15245 1/20 0.39
ABCC4 O15439 1/20 0.39
CACNA1G O43497 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6479819 0.79 ALDH1A1 (0.54) ACHEBCHEALDH1A1HSD17B10CYP1A2
SCHEMBL11870225 0.72 MAPT (0.50) ACHEBCHEALDH1A1HSD17B10CYP1A2
SCHEMBL2883734 0.70 ALDH1A1 (0.56) ACHEALDH1A1HSD17B10CYP1A2CYP2D6
SCHEMBL4059612 0.69 ADAM17 (0.48) ACHEBCHEALDH1A1HSD17B10CYP1A2
SCHEMBL9735885 0.69 ACHE (0.62) ACHEBCHEALDH1A1HSD17B10CYP1A2
SCHEMBL30661688 0.68 DCPS (0.46) ACHEBCHEALDH1A1HSD17B10CYP1A2
SCHEMBL9735659 0.67 ACHE (0.68) ACHEBCHEALDH1A1HSD17B10CYP1A2
SCHEMBL4050645 0.67 ADAM17 (0.60) ACHEALDH1A1HSD17B10CYP1A2CYP2D6
SCHEMBL9167709 0.66 ACHE (0.62) ACHEBCHEALDH1A1HSD17B10CYP1A2
SCHEMBL9737220 0.64 ACHE (0.68) ACHEBCHEALDH1A1HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed